Q BioMed Inc. (OTCMKTS:QBIO) Short Interest Update

Q BioMed Inc. (OTCMKTS:QBIOGet Rating) was the target of a large increase in short interest during the month of December. As of December 30th, there was short interest totalling 189,900 shares, an increase of 21.2% from the December 15th total of 156,700 shares. Based on an average daily trading volume, of 1,488,100 shares, the days-to-cover ratio is currently 0.1 days.

Q BioMed Stock Performance

Shares of OTCMKTS:QBIO opened at $0.01 on Friday. The firm’s fifty day moving average is $0.01 and its 200-day moving average is $0.03. Q BioMed has a 52 week low of $0.01 and a 52 week high of $0.49. The firm has a market cap of $909,090.00, a PE ratio of -0.04 and a beta of 2.44.

Q BioMed (OTCMKTS:QBIOGet Rating) last released its quarterly earnings results on Thursday, November 3rd. The company reported ($0.03) EPS for the quarter. The business had revenue of $0.03 million during the quarter.

About Q BioMed

(Get Rating)

Q BioMed Inc, a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. The company offers Strontium Chloride SR89 and Metastron, a radiopharmaceutical therapeutic for the treatment of metastatic bone cancer pain.

Read More

Receive News & Ratings for Q BioMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Q BioMed and related companies with MarketBeat.com's FREE daily email newsletter.